We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Alcon, Inc. (NYSE:ACL) announced today that the Australian Therapeutic Goods Administration (TGA) has approved RETAANE(R suspension (15mg anecortave acetate suspension) for the treatment of subfoveal choroidal neovascularization (CNV) due to exudative age-related macular degeneration (AMD) where there is a classic component.
Zila, Inc.,(Nasdaq: ZILA - News), announced that its wholly owned subsidiary, Zila Nutraceuticals, Inc., has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region.
The Indian Task Force under the Chairmanship of Dr. Pronab Sen, Principal Advisor, Planning Commission has recommended, inter-alia, to establish a National Authority on Drugs and Therapeutics (NADT) as a long term objective.
GW Pharmaceuticals has agreed a deal for Spain's Almirall to market its pioneering cannabis-based medicine, Sativex, in European countries excluding the UK, sending its shares higher on Monday.
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, announced today that it has received approvals of generic versions of its lansoprazole formulations in the UK.